Abstract: A lightning rod with an electric double layer and electric dipole moment type discharge amplification function, the lightning rod including: a support member (100) for moving a lightning current to the ground; an emission member (200) fitted to the support member (100) to collect charges of the ground according to the approach of a thundercloud and thus emit a large number of ions with the opposite polarity to the polarity of the thundercloud; ground charge chargers (300) fitted to the support member (100) and having spaces formed therein to charge the charges of the ground; an insulation member (400) disposed on top of the emission member (200); and discharge induction members (500) fixedly disposed on top and underside of the emission member (200) by means of the insulation member (400).

Abstract: The present invention relates to a monoclonal antibody to human ?ig-h3 and the use thereof. More particularly, it relates to a monoclonal antibody to the human ?ig-h3 protein, wherein the epitope of the monoclonal antibody is the H1 region of the fourth fas-1 domain of the human ?ig-h3 protein. The monoclonal antibody can specifically recognize the human ?ig-h3 protein in tissue, and so will be useful in diagnosing a disease associated with the increase or decrease of the ?ig-h3 protein. In addition, the monoclonal antibody has the effect of inhibiting the cell adhesion activity of the ?ig-h3 protein.

Abstract: The present invention provides a fusion protein in which a polypeptide comprising Fas-1 domain is fused in frame to N-terminal or C-terminal of human EGF, a nucleotide sequence encoding the fusion protein, an expression vector containing the nucleotide sequence, a transformant transformed by the nucleotide sequence and a method for producing human EGF, improving stability of the protein and enhancing the functions of the same. The present invention provides human EGF with improved stability and enhanced functions by fusing a polypeptide comprising Fas-1 domain having the activities of cell adhesion and wound healing to human EGF.

Abstract: The present invention relates to an extract of Houttuynia cordata and Rubus coreanus, and a composition for the prevention and treatment of allergic diseases, comprising the same. The inventive extract and the composition comprising the same have the effect of preventing and treating allergic diseases by inhibiting the degranulation and histamine release of mast cells. Also, they show no cytotoxicity and thus can be safely use in vivo.